Musk, Ramaswamy will lean on Supreme Court rulings to cut federal agencies [Globe and Mail, The (Toronto, Canada)]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: Globe and Mail, The
to reduce rules that are unnecessary, costly and inefficient. Musk, the billionaire CEO of Tesla and SpaceX, and Ramaswamy, a former Republican presidential candidate and the founder of biotechnology firm Roivant Sciences, have been tasked by President-elect Donald Trump to lead a panel of outside advisers to make efficiency recommendations. The two wrote a Wall Street Journal opinion piece about the panel on Wednesday. Many current federal regulations may exceed the legislative power granted by Congress, they said, citing two Supreme Court cases – 2022's West Virginia v. Environmental Protection Agency and this year's Loper Bright v. Raimondo. The panel will look for such regulations, they added. With an electoral mandate and the 6-3 conservative majority in the Supreme Court, Musk and Ramaswamy said, the panel has an opportunity to enact substantial structural downsizing within the federal government. The panel will give its list of regulations to President Trump, “who can, by
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- U.S. can become a crypto superpower with 'sensible' regulation, Eric Trump says [MSNBC.com]MSNBC.com
- U.S. can become a crypto superpower with ‘sensible' regulation, Eric Trump says [CNBC]CNBC
- Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary SarcoidosisGlobeNewswire
- Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary SarcoidosisGlobeNewswire
- Everything to know about Vivek Ramaswamy, co-lead of the Department of Government Efficiency with Elon Musk [Business Insider]Business Insider
ROIV
Earnings
- 11/12/24 - Miss
ROIV
Analyst Actions
- 11/13/24 - HC Wainwright
ROIV
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 144
- 12/18/24 - Form 144
- ROIV's page on the SEC website